T82440
Erzotabart
TargetMol
DESCRIPTION
Erzotabart, an IgG1-kappa monoclonal antibody targeting CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) in Homo sapiens, exhibits antineoplastic activity [1].
DETAILS
- Cas: 2430792-01-9
- Purity: 98%
- Category: Compound
Lead Time: Please Inquire
Sign in to view pricing